Cargando…
Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy
GOALS: To determine whether patients with a pre-existing PPI treatment had a higher risk of poor evolution (recurrence or death) when diagnosed with a toxicogenic Clostridium difficile digestive infection. BACKGROUND: Previous studies identified pump proton inhibitor (PPI) prescription as a risk fac...
Autores principales: | Dos Santos-Schaller, Ophélie, Boisset, Sandrine, Seigneurin, Arnaud, Epaulard, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828342/ https://www.ncbi.nlm.nih.gov/pubmed/27104118 http://dx.doi.org/10.1186/s40064-016-2058-z |
Ejemplares similares
-
Proton pump inhibitors and the incidence of Clostridium difficile on the intensive care unit
por: Whitehead, I, et al.
Publicado: (2007) -
The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
por: Tawam, Dania, et al.
Publicado: (2021) -
Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection
por: Inghammar, Malin, et al.
Publicado: (2021) -
Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment
por: Bradley, Evan Stuart, et al.
Publicado: (2019) -
515. Estimating the Effect of Proton Pump Inhibitor Stewardship in Reducing Clostridium difficile Transmission
por: Lofgren, Eric, et al.
Publicado: (2018)